END DRUG SHORTAGES ALLIANCE ASSOCI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

JASON CHOU

Phone

3032633452

Tax Period

2025-01-01 to 2025-12-31

END DRUG SHORTAGES ALLIANCE ASSOCIATION, founded in 2021, is a small nonprofit in the Health Care sector that reported $566K in total revenue in fiscal year 2025. Revenue surged 31% from the prior year, signaling strong growth momentum.

Mission

LEAD THE NATION'S ONLY MEMBER-DRIVEN AND INDUSTRY-LED ALLIANCE OF HEALTHCARE AND SUPPLY CHAIN LEADERS WORKING COLLABORATIVELY TO STRENGTHEN ESSENTIAL MEDICINE SUPPLY AND SAFEGUARD PATIENT ACCESS.

Program Service Accomplishments

Program 1

END DRUG SHORTAGES ALLIANCE'S (EDSA) VISION IS TO END DRUG SHORTAGES THROUGH ENSURING ACCESS TO ESSENTIAL MEDICATIONS AND IMPROVING QUALITY OF LIFE FOR PATIENTS WHO RELY ON THESE MEDICATIONS. THIS...

END DRUG SHORTAGES ALLIANCE'S (EDSA) VISION IS TO END DRUG SHORTAGES THROUGH ENSURING ACCESS TO ESSENTIAL MEDICATIONS AND IMPROVING QUALITY OF LIFE FOR PATIENTS WHO RELY ON THESE MEDICATIONS. THIS YEAR, EDSA LAUNCHED ITS MOST AMBITIOUS AND UNIFYING EFFORT: A COORDINATED STRATEGY TO END DRUG SHORTAGES BY SCALING SUCCESSFUL PILOTS, DRIVING POLICY INNOVATION, AND ALIGNING NATIONAL RESILIENCE EFFORTS.2025 MARKED A CRITICAL MILESTONE AS DATA COLLECTION FOR THE DRUG RESILIENCY AND TRANSPARENCY PILOT OFFICIALLY BEGAN. THIS PILOT IS A FIRST-OF-ITS-KIND, COLLABORATIVE EFFORT GUIDED BY A DEDICATED PILOT TASK FORCE OF HEALTH SYSTEM LEADERS, SUPPLY CHAIN EXPERTS, AND OUR RAPID RESPONSE TEAM. (CONTINUED ON SCHEDULE O).THE PILOT IS DESIGNED TO BUILD A SCALABLE, TRANSPARENT SYSTEM THAT ENSURES CONSISTENT ACCESS TO MEDICATIONS,ESTABLISHES INVENTORY STEWARDSHIP BEST PRACTICES, RECOMMENDS BUFFER SUPPLY STRATEGIES, AND SUPPORTS TIMELY DRUG DISTRIBUTION DURING SHORTAGES. PARTICIPATING HOSPITALS AND DISTRIBUTORS SUBMIT WEEKLY BLINDED DATA AND INVENTORY STATUS ON SEVEN ESSENTIAL PEDIATRIC CANCER DRUGS, WHICH ALLOWS US TO SPOT PATTERNS BEFORE THEY BECOME CRISES, ANTICIPATE CHALLENGES AND IMPROVE PLANNING, GUIDE BEST PRACTICES FOR STEWARDSHIP AND BUFFER MANAGENENT. EDSA ADDED 22 MEMBERS IN 2025, GROWING TO 100 ACTIVE MEMBERS ACROSS THE DRUG SUPPLY CHAIN. WITH THIS GROWTH COMES GREATER STRENGTH, GREATER REACH, AND A GREATER ABILITY TO DELIVER RESULTS THAT MATTER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $565,940

Investment Income $0

Other Revenue $0

TOTAL REVENUE $565,940

Expense Breakdown

Grants Paid $0

Salaries & Benefits $323,618

Fundraising Expenses $0

Other Expenses $295,778

TOTAL EXPENSES $619,396

Year-over-Year Comparison

	2025	2024	Change
Revenue	$565,940	$431,000	+0.3%
Expenses	$619,396	$220,328	+1.8%
Net Income	$-53,456	$210,672	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JASON CHOU	CHAIR	1.00	Officer Director	$0	$0	$0
MIKE WASCOVICH	CHAIR ELECT	1.00	Officer Director	$0	$0	$0
TERRI LYLE WILSON	PAST CHAIR	1.00	Officer Director	$0	$0	$0
MITTAL SUTARIA	FOUNDING MEMBER	1.00	Officer Director	$0	$0	$0
JUSTIN SCHNEIDER	TREASURER	1.00	Officer Director	$0	$0	$0
STEPHEN COLVILL	DIRECTOR	1.00	Director	$0	$0	$0
SCOTT MILLER	DIRECTOR	1.00	Director	$0	$0	$0
ERIC TICHY	DIRECTOR	1.00	Director	$0	$0	$0
FAIEZ USMAN	DIRECTOR	1.00	Director	$0	$0	$0
LINDSEY THOMAS	DIRECTOR	1.00	Director	$0	$0	$0
LAURA BRAY	DIRECTOR	1.00	Director	$0	$0	$0
MIKE GANIO	DIRECTOR	1.00	Director	$0	$0	$0
CARRIE DUNFORD	DIRECTOR	1.00	Director	$0	$0	$0
MEERA BHAVSAR	DIRECTOR	1.00	Director	$0	$0	$0
LAUREN DEREUS	DIRECTOR	1.00	Director	$0	$0	$0
JENNIFER BAIR	DIRECTOR	1.00	Director	$0	$0	$0
NEAL GERVAIS	DIRECTOR	1.00	Director	$0	$0	$0
VIMALA RAGHAVENDRAN	DIRECTOR	1.00	Director	$0	$0	$0
APRIL GILES	EXECUTIVE DIRECTOR	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$565,940	$619,396	$667,810	$-53,456
2024	$431,000	$220,328	$769,251	$210,672
2023	$358,600	$194	$358,406	$358,406

END DRUG SHORTAGES ALLIANCE ASSOCIATION